ACT jumps on encouraging data for stem cell vision treatment
24 January 2012
Donna Young
Please Login to read the full article.
24 January 2012
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- Regeneron leaps on positive FDA review of wet AMD drug
- CATT 2-year results add fuel to Avastin/Lucentis debate, with implications for Eylea
- Regeneron's Eylea wins US OK; bests Lucentis in pricing, dosing
- US FDA: Tainted compounded Avastin linked to serious eye infections, blindness
FEATURES
Other Informa Features
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
